Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.450, 2004-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
QOL effects may be decisive for similar COPD treatments
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 578, 2009-01 ,pp. :
Access to resources
Recommend
QOL effects of C-reactive protein levels in diabetes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 442, 2003-01 ,pp. :
Sibutramine beneficial in obesity with hyperlipidaemia
Inpharma, Vol. 1, Iss. 1314, 2001-01 ,pp. :
Sibutramine and the management of obesity
By Poston Walker S Carlos Foreyt John P
Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. :
Sibutramine beneficial in adolescent obesity
Inpharma, Vol. 1, Iss. 1383-1384, 2003-01 ,pp. :